期刊文献+

22种中药醇提物抑制蛋白质非酶糖基化作用的研究 被引量:15

Inhibitory Effects of Alcohol Extracts from 22 Specie of Herbs on Nonenzymatic glycosylation in vitro
下载PDF
导出
摘要 比较22种中药醇提物和氨基胍对体外蛋白质非酶糖基化反应的影响。分别将上述22种中药各5g,用乙醇提取、浓缩并定容至100ml,取1ml提取液与1ml磷酸缓冲液混合,90℃水浴40min,然后与乙二醛和牛血清白蛋白混合,反应混合液于37℃孵育15d,用荧光法测定糖基化产物的自发荧光值,计算不同中药醇提物对体外蛋白质非酶糖基化反应的抑制率。结果表明,在检测的浓度范围内,抑制率最高的是槐米(抑制率为96.7%),其次为大黄(抑制率为93.79%)和黄芩(抑制率为93.15%),它们都显著高于氨基胍的抑制率(89.56%)。槐米、大黄和黄芩的乙醇提取物可明显抑制体外蛋白质糖基化反应的结果预示它们在防治糖尿病血管并发症方面有应用潜力。 The inhibitory effects of alcohol extracts from 22 species of herbs, aminoguanidine, and metformin on the non- enzymatic glycosylation of protein in vitro were compared. The herb extracts were prepared by extracting the herbs with alcohol, concentrated and adjusted the solutions to 100 ml. The extracted solutions (1 ml) were mixed separately with PBS (1 ml), and heated in 90℃ for 40 rain to remove alcohol. The resulting samples mixed with the reactive solution containing glyoxal and bovine serum albumin were incubated at 37℃ for 14 d. The AGEs contents were assayed by the specific fluorescence with emission at 440 nm upon excitation at 370 nm. Results indicated that the bud of Sophorajaponica holds the highest inhibitory activity (96.7%) on the non-enzymatic glycosylation reaction. And Radix scutellariae (93.79%) and Rheum glabricaule (93.15%) also show higher inhibitory rate than both the other herbs and the positive control aminoguanidine (89.56%)(p 〈 0.01). Our findings showed that the extracts of bud of S. japonica, R glabricaule and R. scutellariae can inhibit non-enzymatic glycosylation of protein in vitro, and may be useful for developing agents to treat diabetes and vascular complications prospectively.
出处 《食品科学》 EI CAS CSCD 北大核心 2007年第5期41-44,共4页 Food Science
基金 江苏省自然科学基金项目(BK2003047)
关键词 蛋白质 非酶糖基化反应 抑制率 中药 乙醇提取物 non-enzymatic glycosylation of protein inhibitory ratio herbs alcohol extract
  • 相关文献

参考文献25

  • 1VLASSARA H.Advanced glycosylation end-products and atherosclerosis[J].Ann Med,1996,28:419-426.
  • 2孙子林,刘乃丰,弓玉祥,童嘉毅,王伯荣.蛋白质非酶糖基化导致理化性状改变[J].铁道医学,2000,28(5):290-293. 被引量:2
  • 3陈睿杰,刘允坚.糖尿病治疗药物的研究现状[J].广东药学院学报,2001,17(2):131-133. 被引量:28
  • 4YURI O,SHIN A K O,TAKUZI Y,et al.Increased serum levels of advanced glycation end-products and diabetic complications[J].Diabetes Res and Clin Prac,1998,41:131-137.
  • 5WU C C,HUANG C M,LIN C H,et al.Advanced glycosylation end products induce NF-к B dependent iNOS expression in RAW264.7cells[J].Mol cell endocrinol,2002,194:9-17.
  • 6BUNN H F,HANEY D N,GABBAY K H,et al.Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c[J].Biochem Biophys Res Commun,1975,67:103-109.
  • 7IDO Y,WILLIAMSON J R.Hyperglycemic cytosolic reductive stress pseudohypoxia':implications for diabetic retinopathy[J].Invest Ophthalmol Vis Sci,1997,38:1467-1470.
  • 8VANDEN E M K,NYENGAARD J R,OSTROW E,et al.Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism.Implications for diabetic retinopathy[J].Invest Ophthalmol Vis Sci,1995,36:1675-1685.
  • 9WILLIAMSON JR,CHANG K,FRANGOS M,et al.Hyperglycemic pseudohypoxia and diabetic complications[J].Diabetes,1993,42:801-813.
  • 10IMARIAGA Y,SAKATA N,TAKEBAYASHI S,et al.In vivo and in vitro evidence for the glycosidation of low density lipoprotein in human atherosclerotic plaques[J].Atherosclerosis,2000,150:343-355.

二级参考文献38

  • 1李才,邓义斌,王丽娟,张秀云,邹雅斌,侯芳玉.实验性糖尿病大鼠肾脏自由基防御机能的改变及其意义[J].中国病理生理杂志,1995,11(6):638-641. 被引量:32
  • 2顾关云,蒋昱.植物降血糖成分的研究概况[J].国外医药(植物药分册),1997,12(2):55-60. 被引量:21
  • 3[1]King G L,Brownlee M.The cellular and molecular mechanisms of diabetic complications [J].Endocrinol Metab Clin North Am,1996,25(2):255-70.
  • 4[3]Farmar J, Ulrich P, Cerami A. Novel pyrroles from sulfite-inhibited Mail-lard reactions:insight into the mechanism of inhibition[J]. J Org Chem,1988, 53:2346-9.
  • 5[4]Wrobel K,Wrobe1 K,Garay-Sevilla M E,et al. Novel analytical approachto monitoring advanced glycosytation end products in human serum with on- line spectrophotometric and spectrofluorometric detection in a flow sys-tem[ J]. Clin Chem, 1997,43(3): 1563 - 9.
  • 6[5]Vlassara H, Bucala R, Striker L. Biology of disease. Pathogenic effects ofadvanced glycosylation: biochemical, biologic, and clinical implications fordiabetes and aging[J]. Lab Invest, 1994,70:138 - 51.
  • 7[6]Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin-AGE: a circulatingmarker of advanced glycosylation[ J] .Science, 1992,258:651 - 3.
  • 8[7]Ghiggeri G M,C, Candiano G,Delfino G,et al. Flectrial charge of serum and urinaryalbumin in normal and diabetic humans[J].Kidney Int,1985,28:168-77.
  • 9[8]Wu J T,Tu M C,Zhung P. Advanced glycation end products(AGE): char-acterization of the products from the reaction between D-glucose and serumalbumin[J].J Clin Lab Anal, 1996,10:21-34.
  • 10[9]Boyd White J, Williams J C Jr. Effect of cross-linking on matrix perme-ability. A model for AGE-modified basement membranes [ J ]. Diabetes,1996,45(3): 348 - 53.

共引文献37

同被引文献222

引证文献15

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部